Equity Profile

IQV

IQVIA Holdings Inc.

Health CareLife Sciences Tools & Services$39.8B

Jul21Tue

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

IQVIA Holdings Inc. operates in the health care sector, focusing on life sciences tools and services....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and is closely watched by investors.

$3.27

Revenue

Revenue growth reflects the company's ability to expand its business and capture market share.

$4.4B

Wall Street expectations, options signals, track record, and call prep available with Pro.

IQV Q2-2026 Earnings Preview

Context

Company Snapshot

IQVIA Holdings Inc. operates in the health care sector, focusing on life sciences tools and services. The company plays a crucial role in providing data analytics and technology solutions to pharmaceutical and biotechnology companies, which is increasingly important as the industry embraces digital transformation and data-driven decision-making.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+11.71%

Avg Stock Reaction

+2.48%

Last Quarter Recap

In Q1-2026, IQVIA reported an EPS of $2.90, exceeding expectations by 15.68%. The stock reacted positively, gaining 9.62% the next day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect IQVIA to report strong earnings this quarter, with a consensus EPS of $3.27. Investors are keen to see if the company can maintain its growth trajectory.

Bull Case

If IQVIA beats EPS expectations and shows strong revenue growth, it could signal robust demand for its services, leading to a positive market reaction.

Bear Case

Conversely, if the company misses EPS estimates or provides weak guidance, it may raise concerns about its growth prospects, leading to a negative stock response.

Key Metrics to Watch

EPS

$3.27

Earnings per share is a key indicator of profitability and is closely watched by investors.

Revenue

$4.4B

Revenue growth reflects the company's ability to expand its business and capture market share.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will IQVIA's EPS exceed the consensus estimate of $3.27?

A beat on EPS would reinforce investor confidence in the company's ability to generate profits and could lead to a positive stock reaction.

What is the outlook for revenue growth this quarter?

Guidance on revenue growth will be critical in assessing the company's market position and future prospects.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating IQVIA's potential for revenue growth due to its strong position in the life sciences sector, which is increasingly reliant on data analytics.

Supporting Evidence

IQVIA has consistently beaten EPS estimates in the past, indicating strong operational performance.

The options market's implied move of 16.03% suggests that traders expect significant volatility, which could reflect underlying strength not fully appreciated by analysts.

Key Risk

If revenue growth exceeds expectations, it could challenge the current consensus view and lead to a re-evaluation of the stock's potential.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is pivotal as it will either validate the company's growth strategy or highlight potential weaknesses.

Bull Confirmed If

An EPS of $3.35 or higher would confirm strong operational performance and market demand.

Bear Confirmed If

An EPS below $3.20 would raise concerns about the company's growth trajectory.

Pre-Earnings Positioning

Options Market

Implied Move

±16.03%

Historical Avg

±7.3%

Pricing rich

The options market is pricing in a significant potential movement in the stock, indicating heightened uncertainty ahead of the earnings report.

Options are pricing ±16.0% while IQV has averaged ±7.3% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

51.6%

Calls (204K)P/C Ratio: 0.32Puts (69K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If IQVIA beats expectations, history suggests the stock could rise by about 2.48% on the following day, confirming a strong growth narrative.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further clarity from management.

Miss

A miss could lead to a decline in the stock, with historical patterns indicating an average drop of around 4.01% following disappointing results.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

0 buys·1 sell

Members

House only

Est. Notional

$50,001.00–$100,000.00

disclosed dollar ranges

Most Active Members

R-OKKevin HernRep.
1

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new client acquisitions or contracts.
2Insights into the demand for data analytics services in the life sciences sector.
3Management's commentary on competitive pressures and market trends.
4Guidance on future revenue growth and profitability targets.
5Any changes in operational strategy or focus areas.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

ICICI Bank Limited

Company Snapshot

IQVIA Holdings Inc. operates in the health care sector, focusing on life sciences tools and services....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and is closely watched by investors.

$3.27

Revenue

Revenue growth reflects the company's ability to expand its business and capture market share.

$4.4B

Wall Street expectations, options signals, track record, and call prep available with Pro.

IQV Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+11.71%

Avg Stock Reaction

+2.48%

Last Quarter Recap

In Q1-2026, IQVIA reported an EPS of $2.90, exceeding expectations by 15.68%. The stock reacted positively, gaining 9.62% the next day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect IQVIA to report strong earnings this quarter, with a consensus EPS of $3.27. Investors are keen to see if the company can maintain its growth trajectory.

Bull Case

If IQVIA beats EPS expectations and shows strong revenue growth, it could signal robust demand for its services, leading to a positive market reaction.

Bear Case

Conversely, if the company misses EPS estimates or provides weak guidance, it may raise concerns about its growth prospects, leading to a negative stock response.

Key Metrics to Watch

EPS

$3.27

Earnings per share is a key indicator of profitability and is closely watched by investors.

Revenue

$4.4B

Revenue growth reflects the company's ability to expand its business and capture market share.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will IQVIA's EPS exceed the consensus estimate of $3.27?

A beat on EPS would reinforce investor confidence in the company's ability to generate profits and could lead to a positive stock reaction.

What is the outlook for revenue growth this quarter?

Guidance on revenue growth will be critical in assessing the company's market position and future prospects.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating IQVIA's potential for revenue growth due to its strong position in the life sciences sector, which is increasingly reliant on data analytics.

Supporting Evidence

IQVIA has consistently beaten EPS estimates in the past, indicating strong operational performance.

The options market's implied move of 16.03% suggests that traders expect significant volatility, which could reflect underlying strength not fully appreciated by analysts.

Key Risk

If revenue growth exceeds expectations, it could challenge the current consensus view and lead to a re-evaluation of the stock's potential.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is pivotal as it will either validate the company's growth strategy or highlight potential weaknesses.

Bull Confirmed If

An EPS of $3.35 or higher would confirm strong operational performance and market demand.

Bear Confirmed If

An EPS below $3.20 would raise concerns about the company's growth trajectory.

Pre-Earnings Positioning

Options Market

Implied Move

±16.03%

Historical Avg

±7.3%

Pricing rich

The options market is pricing in a significant potential movement in the stock, indicating heightened uncertainty ahead of the earnings report.

Options are pricing ±16.0% while IQV has averaged ±7.3% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

51.6%

Calls (204K)P/C Ratio: 0.32Puts (69K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If IQVIA beats expectations, history suggests the stock could rise by about 2.48% on the following day, confirming a strong growth narrative.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further clarity from management.

Miss

A miss could lead to a decline in the stock, with historical patterns indicating an average drop of around 4.01% following disappointing results.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

0 buys·1 sell

Members

House only

Est. Notional

$50,001.00–$100,000.00

disclosed dollar ranges

Most Active Members

R-OKKevin HernRep.
1

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new client acquisitions or contracts.
2Insights into the demand for data analytics services in the life sciences sector.
3Management's commentary on competitive pressures and market trends.
4Guidance on future revenue growth and profitability targets.
5Any changes in operational strategy or focus areas.